Protagenic Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| WARBERG ASSET MANAGEMENT LLC | 02/13/2025 | 170,242 | $1,038 | -3.92% | 3.81% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 67,173 | $302 | 44.10% | 1.50% |
| GTS SECURITIES LLC | 02/18/2025 | 25,400 | $76 | 0.40% | 0.57% |
| TWO SIGMA SECURITIES, LLC | 02/14/2025 | 17,500 | $61 | 100.00% | 0.39% |
| UBS GROUP AG | 02/14/2025 | 360 | $1 | 100.00% | 0.01% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Protagenic Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 6 institutional investors and hedge funds held shares of Protagenic Therapeutics, Inc.. The most heavily invested institutionals were:
Warberg Asset Management LLC: 170,242
SUSQUEHANNA INTERNATIONAL GROUP, LLP: 67,173
GTS SECURITIES LLC: 25,400
TWO SIGMA SECURITIES, LLC: 17,500
UBS Group AG: 360
BANK OF AMERICA CORP /DE/: 0
6.28% of Protagenic Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 280,675 shares in the last 24 months. This purchase volume represents approximately $0 in transactions.